We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Olaparib Successfully Treats Prostate Cancers With Genetic Fault in Clinical Trial

News   Sep 21, 2020 | Original story from ICR

 
Olaparib Successfully Treats Prostate Cancers With Genetic Fault in Clinical Trial
 
 
Advertisement
 

RELATED ARTICLES

Anti-Inflammatory Drug Reduces Disease Progression in Preclinical Model of MS

News

Intranasal administration of an anti-inflammatory drug helped reduce disease progression in a preclinical model of multiple sclerosis, according to recent research out of the University of Alberta.

READ MORE

Biomarker That Appears Before Stomach Cancer Develops May Aid Early Detection

News

A promising new biomarker that appears in patients before stomach cancer develops may help with early detection of the disease and improve patient response to therapy, according to findings in a study led by University of Arizona Health Sciences researchers.

READ MORE

Potential Global Hesitancy To Accept a COVID-19 Vaccine

News

A research team from the City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), the Barcelona Institute for Global Health (ISGlobal), the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine (LSHTM), and Georgetown University Law School announced today that Nature Medicine has published their research revealing potential global hesitancy to accept a COVID-19 vaccine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE